{"id":1048,"date":"2022-01-14T20:08:22","date_gmt":"2022-01-14T20:08:22","guid":{"rendered":"https:\/\/mailinvest.blog\/index.php\/2022\/01\/14\/unbounce-acquires-leadsrx\/"},"modified":"2022-01-14T20:08:22","modified_gmt":"2022-01-14T20:08:22","slug":"unbounce-acquires-leadsrx","status":"publish","type":"post","link":"https:\/\/mailinvest.blog\/index.php\/2022\/01\/14\/unbounce-acquires-leadsrx\/","title":{"rendered":"Unbounce Acquires LeadsRx"},"content":{"rendered":"

<\/a>\n<\/p>\n

\n

Conversion intelligence platform Unbounce<\/a> acquired LeadsRx<\/a>, a marketing analytics SaaS platform that aims to streamline marketing channel performance measurement. Together, the two companies intend to unlock new opportunities for marketing and business growth and position Unbounce to bring marketing attribution to SMB customers.<\/p>\n<\/p><\/div>\n

\n

Serving more than 5,000 global and local brands and agencies such as iHeartMedia and Rakuten Advertising, LeadsRx collects anonymous customer data from 2.5 billion customer touchpoints, empowering customers to make more informed decisions faster.<\/p>\n

\u201cAttribution is one of the most painful parts of marketing \u2014 validating your costs and ROI to your CEO, clients and investors is harder than ever as competition and new marketing channels continue to grow at a rapid pace,” said Tamara Grominsky, Chief Strategy Officer of Unbounce, in a statement. “LeadsRx solves these pain points for marketers by showing them which channels are performing and which aren\u2019t. By combining LeadsRx\u2019s wealth of new data with our conversion intelligence platform, we have the opportunity to deliver conversion value to marketers across a wider spectrum of the marketing funnel. We\u2019re thrilled to welcome LeadsRx to the Unbounce team as we continue our journey of bringing conversion intelligence solutions to marketers around the world.\u201d<\/p>\n<\/p><\/div>\n